IL6 and diabetic macular edema: Elevated ocular IL−6 correlates with greater severity of diabetic macular edema, and experimental IL−6 blockade reduces vascular leakage in preclinical models, highlighting its contributory role in barrier failure and inflammatory amplification (78, 81).